Haplotype associations with quantitative traits in the presence of complex multilocus and heterogeneous effects

Genetic Epidemiology

Volumn 33, Issue 1, 2009, Pages 63-78

  Shibata, Kyoko ^a   Diatchenko, Luda ^b   Zaykin, Dmitri V ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Complex disease; Epistasis; Gene gene interactions; Haplotype association

Indexed keywords

CATECHOL METHYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; EPISTASIS; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC TRAIT; HAPLOTYPE; HUMAN; MATHEMATICAL ANALYSIS; MULTILOCUS SEQUENCE TYPING; NOCICEPTION; NORMAL HUMAN; PHENOTYPE; QUANTITATIVE TRAIT; SCORING SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL;

ADOLESCENT; ADULT; ALLELES; CATECHOL O-METHYLTRANSFERASE; CHROMOSOME MAPPING; COHORT STUDIES; EPIDEMIOLOGY, MOLECULAR; EPISTASIS, GENETIC; FEMALE; HAPLOTYPES; HUMANS; LIKELIHOOD FUNCTIONS; LINKAGE DISEQUILIBRIUM; MODELS, GENETIC; MODELS, STATISTICAL; PAIN THRESHOLD; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT, HERITABLE; YOUNG ADULT;

EID: 61849173808     PISSN: 07410395     EISSN: 10982272     Source Type: Journal    
DOI: 10.1002/gepi.20358     Document Type: Article

References (53)

1. Allen A, Satten G. 2008. Robust estimation and testing of haplotype effects in case-control studies. Genet Epidemiol 32:29-40.
2. Balding DJ. 2003. Likelihood-based inference for genetic correlation coefficients. Theor Popul Biol 63:221-230.
3. Bartlett M. 1937. Properties of sufficiency and statistical tests. Proc R Soc Lond A Math Phys Sci 160:268-282.
4. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B 57:289-300.
5. Box G, Cox D. 1964. An analysis of transformations. J R Stat Soc B 26:211-252.
6. Bray NJ, Buckland PR, Williams NM, Williams HJ, Norton N, Owen MJ, O'Donovan MC. 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73:152-161.
7. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, Kolachana BS, Hyde TM, Herman MM, Apud J, Egan MF, Kleinman JE, Weinberger DR. 2004. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
8. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I, Goldman D, Xu K, Shabalina SA, Shagin D, Max MB, Makarov SS, Maixner W. 2005. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 14:135-143.
9. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB, Goldman D, Maixner W. 2006. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 125:216-224.
10. Diatchenko L, Nackley AG, Slade GD, Belfer I, Max MB, Goldman D, Maixner W. 2007. Responses to Drs. Kim and Dionne regarding comments on Diatchenko, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006;125:216-24. Pain 129:366-370.
11. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98:6917-6922.
12. Elston R. 1991. On Fisher's method of combining p-values. Biom J 33:339-345.
13. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D. 2003. Genetic origins of anxiety in women: a role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13:33-41.
14. Epstein M, Satten G. 2003. Inference on haplotype effects in casecontrol studies using unphased genotype data. Am J Hum Genet 73:1316-1329.
15. Epstein MP, Allen AS, Satten GA. 2007. A simple and improved correction for population stratification in case-control studies. Am J Hum Genet 80:921-930.
16. Karayiorgou M, Sobin C, Blundell ML, Galke BL, Malinova L, Goldberg P, Ott J, Gogos JA. 1999. Family-based association studies support a sexually dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry 45:1178-1189.
17. Kern AD, Kondrashov FA. 2004. Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Nat Genet 36:1207-1212.
18. Kirby DA, Muse SV, Stephan W. 1995. Maintenance of pre-mRNA secondary structure by epistatic selection. Proc Nat Acad Sci 92:9047-9051.
19. Kondrashov AS, Sunyaev S, Kondrashov FA. 2002. Dobzhansky- Muller incompatibilities in protein evolution. Proc Natl Acad Sci USA 99:14878-14883.
20. Kraft P, Stram D. 2007. Re: the use of inferred haplotypes in downstream analysis. Am J Hum Genet 81:863-865.
21. Kraft P, Cox D, Paynter R, Hunter D, De Vivo I. 2005. Accounting for haplotype uncertainty in matched association studies: a comparison of simple and flexible techniques. Genet Epidemiol 28:261-272.
22. Lin D. 2004. Haplotype-based association analysis in cohort studies of unrelated individuals. Genet Epidemiol 26:255-264.
23. Lin D, Huang B. 2007. Reply to Peter Kraft and Daniel O. Stram. Am J Hum Genet 81:865-866.
24. Lin D, Zeng D. 2006. Likelihood-based inference on haplotype effects in genetic association studies. J Am Stat Assoc 101:89-104.
25. Lin D, Zeng D, Millikan R. 2005. Maximum likelihood estimation of haplotype effects and haplotype-environment interactions in association studies. Genet Epidemiol 29:299-312.
26. Lin PI, Vance JM, Pericak-Vance MA, Martin ER. 2007. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 80:531-538.
27. Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Meln K, Julkunen I, Taskinen J. 1995. Kinetics of human soluble and membrane-bound catechol O-methyltransferase: a revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34:4202-4210.
28. Luo X, Kranzler H, Zuo L, Wang S, Schork N, Gelernter J. 2006. Diplotype trend regression analysis of the ADH gene cluster and the ALDH2 gene: multiple significant associations with alcohol dependence. Am J Hum Genet 78:973-987.
29. Mannisto PT, Kaakkola S. 1999. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 51:593-628.
30. Meyer-Lindenberg A, Nichols T, Callicott JH, Ding J, Kolachana B, Buckholtz J, Mattay VS, Egan M, Weinberger DR. 2006. Impact of complex genetic variation in COMT on human brain function. Mol Psychiatry 11:867-877.
31. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. 2006. Human catechol- O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 314:1930-1933.
32. Nackley AG, Tan KS, Fecho K, Flood P, Diatchenko L, Maixner W. 2007. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 128:199-208.
33. Nielsen DM, Weir BS. 1999. A classical setting for associations between markers and loci affecting quantitative traits. Genet Res 74:271-277.
34. Oroszi G, Goldman D. 2004. Alcoholism: genes and mechanisms. Pharmacogenomics 5:1037-1048.
35. Palmatier MA, Pakstis AJ, SpeedW, Paschou P, Goldman D, Odunsi A, Okonofua F, Kajuna S, Karoma N, Kungulilo S, Grigorenko E, Zhukova OV, Bonne-Tamir B, Lu RB, Parnas J, Kidd JR, DeMille MMC, Kidd KK. 2004. COMT haplotypes suggest P2 promoter region relevance for schizophrenia. Mol Psychiatry 9:859-870.
36. Schaid D, Rowland C, Tines D, Jacobson R, Poland G. 2002. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 70:425-434.
37. Shi MM, Bleavins MR, de la Iglesia FA. 1999. Technologies for detecting genetic polymorphisms in pharmacogenomics. Mol Diagn 4:343-351.
38. Shibata K, Ito T, Kitamura Y, Iwasaki N, Tanaka H, Kamatani N. 2004. Simultaneous estimation of haplotype frequencies and quantitative trait parameters: applications to the test of association between phenotype and diplotype configuration. Genetics 168:525-539.
39. Shifman S, Bronstein M, Sternfeld M, Pisant-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. 2002. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71:1296-1302.
40. Simes R. 1986. An improved Bonferroni procedure for multiple tests of significance. Biometrika 73:751-754.
41. Stram D, Leigh Pearce C, Bretsky P, Freedman M, Hirschhorn J, Altshuler D, Kolonel L, Henderson B, Thomas D. 2003. Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 55:179-190.
42. Tregouet D, Barbaux S, Escolano S, Tahri N, Golmard J, Tiret L, Cambien F. 2002. Specific haplotypes of the P-selectin gene are associated with myocardial infarction. Hum Mol Genet 11:2015-2023.
43. Tzeng J, Wang C, Kao J, Hsiao C. 2006. Regression-based association analysis with clustered haplotypes through use of genotypes. Am J Hum Genet 78:231-242.
44. Valle T, Tuomilehto J, Bergman R, Ghosh S, Hauser E, Eriksson J, Nylund S, Kohtamaki K, Toivanen L, Vidgren G, Tuomilehto-Wolf E, Ehnholm C, Blaschak J, Langefeld CD, Watanabe RM, Magnusson V, Ally DS, Hagopian WA, Ross E, Buchanan TA, Collins F, Boehnke M. 1998. Mapping genes for NIDDM. Design of the Finland-United States Investigation of NIDDM Genetics (FUSION) Study. Diabetes Care 21:949-958.
45. Weir BS. 1996. Genetic Data Analysis II. Sunderland, MA: Sinauer Associates.
46. Wright S. 1951. The genetical structure of populations. Ann Eugen 15:323-354.
47. Xie R, Stram D. 2005. Asymptotic equivalence between two score tests for haplotype-specific risk in general linear models. Genet Epidemiol 29:166-170.
48. Zaykin DV, Shibata K. 2008. Genetic flip-flop without an accompanying change in linkage disequilibrium. Am J Hum Genet 82:794-796.
49. Zaykin D, Westfall P, Young S, Karnoub M, Wagner M, Ehm M. 2002. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53:79-91.
50. Zaykin DV, Zhivotovsky LA, Czika W, Shao S, Wolfinger RD. 2007. Combining p-values in large-scale genomics experiments. Pharm Stat 6:217-226.
51. Zhao L, Li S, Khalid N. 2003. A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies. Am J Hum Genet 72:1231-1250.
52. Zhu G, Lipsky RH, Xu K, Ali S, Hyde T, Kleinman J, Akhtar LA, Mash DC, Goldman D. 2004. Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 50 nuclease assay. Psychopharmacology 177:178-184.
53. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D. 2003. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 299:1240-1243.